Achieve Life Sciences Ownership | Who Owns Achieve Life Sciences?
Achieve Life Sciences Ownership Summary
Achieve Life Sciences is owned by 50.95% institutional investors, 9.77% insiders, and 39.28% retail investors. Propel bio management is the largest institutional shareholder, holding 7.07% of ACHV shares. Franklin Biotechnology Discv A(acc)USD is the top mutual fund, with 4.50% of its assets in Achieve Life Sciences shares.
ACHV Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Achieve Life Sciences | 50.95% | 9.77% | 39.28% |
Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Propel bio management | 2.45M | 7.07% | $6.55M |
Nantahala capital management | 898.88K | 2.59% | $2.40M |
Adar1 capital management | 43.17K | 0.12% | $115.27K |
Millennium management | 22.10K | 0.06% | $59.01K |
Pale fire capital se | - | - | - |
Squarepoint ops | - | - | - |
Sofinnova investments | - | - | - |
Eversource wealth advisors | - | - | - |
Dumac | - | - | - |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Propel bio management | 2.45M | 7.61% | $6.55M |
Nantahala capital management | 898.88K | 0.10% | $2.40M |
Adar1 capital management | 43.17K | 0.02% | $115.27K |
Eversource wealth advisors | - | - | - |
Dumac | - | - | - |
Pale fire capital se | - | - | - |
Squarepoint ops | - | - | - |
Millennium management | 22.10K | - | $59.01K |
Sofinnova investments | - | - | - |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Nantahala capital management | 898.88K | 0.10% | 244.88K |
Adar1 capital management | 43.17K | 0.02% | 30.00K |
Millennium management | 22.10K | - | 22.10K |
Propel bio management | 2.45M | 7.61% | - |
Eversource wealth advisors | - | - | -26.00 |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Sofinnova investments | - | - | -1.31M |
Dumac | - | - | -50.00K |
Pale fire capital se | - | - | -41.42K |
Squarepoint ops | - | - | -17.52K |
Eversource wealth advisors | - | - | -26.00 |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Millennium management | 22.10K | - | 22.10K | $59.01K |
Sold Out
Holder | Change |
---|---|
Eversource wealth advisors | -26.00 |
Squarepoint ops | -17.52K |
Pale fire capital se | -41.42K |
Dumac | -50.00K |
Sofinnova investments | -1.31M |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Dec 31, 2024 | 73 | 7.35% | 16,339,148 | -3.49% | 50 | 2.10% | 37 | 19.35% | 12 | -14.29% |
Sep 30, 2024 | 68 | 13.33% | 16,929,998 | -8.81% | 49 | 1.68% | 31 | -20.51% | 14 | 55.56% |
Jun 30, 2024 | 60 | 33.33% | 18,565,502 | 12.79% | 54 | 1.25% | 39 | 56.00% | 9 | - |
Mar 31, 2024 | 45 | 36.36% | 16,460,395 | 503.48% | 65 | 34.72% | 25 | 78.57% | 9 | - |
Dec 31, 2023 | 1 | - | 100 | - | - | - | 1 | - | - | - |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Franklin Biotechnology Discv A(acc)USD | 1.56M | 4.50% | - |
Vanguard US Total Market Shares ETF | 1.03M | 2.96% | - |
Vanguard Total Stock Mkt Idx Inv | 1.03M | 2.96% | - |
Franklin Biotechnology Discovery A | 897.27K | 2.59% | - |
iShares Russell 2000 ETF | 790.63K | 2.28% | 134.00 |
Vanguard Institutional Extnd Mkt Idx Tr | 436.63K | 1.26% | - |
Fidelity Small Cap Index | 341.52K | 0.98% | - |
Simplify Propel Opportunities ETF | 217.84K | 0.63% | - |
iShares Russell 2000 Growth ETF | 182.93K | 0.53% | - |
Fidelity Extended Market Index | 180.74K | 0.52% | 2.80K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Mar 17, 2025 | Oki Mark K | Chief Financial Officer | Buy | $28.89K |
Mar 17, 2025 | Stewart Richard Alistair | Chieve Executive Officer | Buy | $28.60K |
Mar 04, 2024 | Stewart Richard Alistair | Executive Chairman | Buy | $45.85K |
Mar 04, 2024 | Stewart Richard Alistair | Executive Chairman | Buy | $49.06K |
Mar 04, 2024 | Bencich John | CEO | Buy | $49.06K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q1 | 2 | - |
2024 Q4 | - | - |
2024 Q3 | - | - |
2024 Q2 | - | - |
2024 Q1 | 4 | - |
ACHV Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools